The AI-Driven Drug Discovery Summit aims to highlight the latest advancements in the application of AI for drug discovery. Over the course of two days, experts from the field will come together to: Explore how AI is enabling researchers to improve hit identification and lead generation through AI-enabled virtual screening of ultra-large chemical libraries; generative AI models for de novo drug design; and the designing and developing of digital twins for hit ID. Understand how recent advances in machine learning methods are improving the accuracy of therapeutic target identification. Connect…

Read more